Delivery Order SPE2DB25D3018-SPE2DB25FUYCB
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency valued at $4,167.89 for the supply of Repatha 140 mg/mL SureClick auto-injector medication. The award was issued on July 18, 2025, with an ultimate completion date of July 21, 2025, under firm fixed-price terms with no set-aside designation. This delivery order represents a competitively awarded transaction under...
- The Defense Logistics Agency awarded a delivery order valued at $2,524.72 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick, a pharmaceutical product used in cardiovascular disease management. The contract was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025, under a firm fixed-price arrangement with no set-aside designation. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,818.23 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a single-unit pharmaceutical procurement under a non-set-aside, competitively awarded contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills...
- The Defense Logistics Agency awarded a $39,071.10 delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with a completion date of July 25, 2025. This non-set-aside, firm fixed-price contract was competitively awarded and represents a single delivery order fulfillment of this specialized cardiovascular medication used to treat high cholesterol. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $1,041.42 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, with an ultimate completion date of July 21, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors, with a ceiling value of $1,388.56. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania, and is scheduled for completion by July 28, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,480.40 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/mL SureClick auto-injectors. The contract was competitively awarded without set-aside designation and carries an ultimate completion date of July 29, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends...
- The Defense Logistics Agency awarded a $1,041.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Repatha 140 mg/mL SureClick auto-injectors, with an ultimate completion date of July 28, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical supply vehicle running through December 2026. The place of...
- On July 22, 2025, the Defense Logistics Agency awarded a delivery order contract valued at $1,041.42 to AmerisourceBergen Drug Corp for the supply of Repatha 140 mg/ml SureClick auto-injectors. This competitive, non-set-aside delivery order utilizes firm fixed pricing and is scheduled for completion by July 23, 2025. The contract will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $19,499.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This non-set-aside contract is scheduled for completion on July 25, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp serves as a critical vendor for federal medical procurement, particularly supporting...
- SPE2DB25D3018Indefinite Delivery Contract
- SPE2DB25D3018-SPE2DB25FUYCBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,185.80 to AmerisourceBergen Drug Corp for Repatha 140 mg/ml SureClick auto-injectors, a specialty pharmaceutical product used in cardiovascular disease management. This firm fixed-price delivery order, awarded on July 28, 2025, with an ultimate completion date of July 29, 2025, was competitively awarded without set-aside restrictions. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a child delivery order under AmerisourceBergen's broader procurement relationship with the federal government for medical supply chain support. This delivery order is issued under AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. Through this comprehensive pharmaceutical prime vendor vehicle, AmerisourceBergen supplies a broad range of medications and medical commodities to support Defense Health Agency and military healthcare systems globally. The company's federal contract portfolio demonstrates consistent capability to deliver specialty pharmaceuticals and medical supplies across multiple therapeutic domains, positioning it as a critical vendor for military medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 7/28/25 |